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The Influence of Cytokines on Altered Pain Thresholds in Obesity 
Introduction 
Obesity continues to be a dramatic problem throughout the globe. The World Health 
Organization (WHO) reports that more than 1.5 billion adults worldwide are overweight; of 
these, over 200 million men and nearly 300 million women meet the criteria for obesity (WHO). 
In the United States, over 78 million adults and about 12.5 million children and adolescents are 
obese (Ogden et al. 2010). 
The obesity epidemic translates to a significant public health concern since obesity is 
associated with many pain related co-morbidities including low back pain , diabetic neuropathy, 
osteoarthritis, headaches, and other musculoskeletal pain conditions (O'arcy 2012). The 
number of pain issues reported to health care providers is increasing exponentially along with 
the obesity epidemic since nearly 50% of obese patients regularly experience pain (Kerns et al. 
2003). Unfortunately, the association between pain and obesity is not clear. It is well 
documented that obesity is a pro-inflammatory stat)and inflammatory markers contribute to the 
development and modulation of pain; therefore, inflammation may be part of the causation 
between obesity and pain (Ray et al. 2011). The objective of this translational literature review 
is to discuss the role of inflammatory markers as modulators of pain in the peripheral and 
central nervous systems in individuals with obesity. 
The Neurophysiology of Pain 
Pain is defined as "an unpleasant sensory and emotional experience that is commonly 
associated with actual or potential tissue damage" (Merskey et al. 1994). In humans, pain is 
always subjective and is affected by past experiences, context, emotions, cognition, gender, 
and even cultural and religious influences (Merskey et al. 1994). Acute pain is associated with 
tissue injury; chronic pain extends beyond normal tissue healing. In the peripheral nervous 
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system, pain receptors, also called nociceptors, are located in the skin and viscera; nociception 
is transmitted by A delta and C afferent nerve fibers. Additional nociceptors are located in the 
muscle and joint; this nociception is transmitted by Group III and IV afferent nerve fibers. 
Nociceptors are activated via four main stimuli : chemical, mechanical, electrical, and thermal. 
After the nocicepter is activated, the pain signal is transmitted along the afferent fiber to the 
dorsal horn of the spinal cord, specifically lamina I and V-VII. Via the spinothalamic tract, the 
pain signal crosses to the opposite side of the spinal cord, ascends through the brain stem to 
the ventroposterior lateral nucleus of the thalamus, and finally to the somatosensory cortex I 
and II . It is here that the sensory aspect of pain is processed. Another ascending pathway, the 
spinomesencephalic tract, transmits pain contralaterally from the spinal cord to the midbrain, 
specifically to the periaqueductal gray matter. Other projections extend from here to the limbic 
system where the emotional and psychological aspects of pain are processed. In addition to 
these ascending pathways, there are descending pathways from the cortex that can excite or 
inhibit pain . Both the peripheral and central nervous system are involved in pain transmission 
and processing (Kandel et al. 2000). 
The Prevalence of Pain in Obese Individuals 
Recent research has documented the incidence of pain with obese individuals throughout the 
lifespan and provided insight into the distinct relation between obesity and pain. Pain 
prevalence and severity have been linked to obesity in adults, the elderly, and children (Ray et 
al. 2011; Hitt et al. 2007; Wachholtz et al. 2009; Stone and Broderick 2012). After controlling for 
demographic and lifestyle variables, obesity is a significant predictor for self-reported pain with 
an increased incidence of pain at each level of obesity (Hitt et al. 2007). Therefore ~ there is a 
dose-response relationship between higher body mass index (BMI) and chronic pain (McCarthy 
et al. 2009). 
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Even specific pain conditions such as low back pain, tension-type or migraine headaches, 
fibromyalgia, abdominal pain, and chronic widespread pain are associated with increased 
weight in adults (Wright et al. 2010). Similarly, children in the overweight category are more 
likely to report musculoskeletal pain or discomfort, most commonly in the knee, back or foot (de 
Sa Pinto et al. 2006; Taylor et al. 2006; Stovitz et al. 2008) and headaches (Bell et al. 2007; 
Hershey et al. 2009). In addition, the impact of pain on functional status and health-related 
quality of life is more significant in individuals with higher BMI compared to normal BMI (Marcus 
2004). The co-occurrence of pain and obesity have an additive negative effect on health-related 
quality of life as evidenced in patients seeking treatment for obesity and for chronic pain 
(Marcus 2004; Barofsky et al. 1997; Janke et al. 2007). Consequently, obese individuals are at 
high risk in developing chronic pain, which negatively impacts their quality of life to a greater 
degree than obesity alone (Marcus 2004). The presence of pain in obesity can also decrease 
participation in physical activities and this can lead to additional weight gain (Taylor et al. 2006). 
Clinical pain is highly evident in individuals with obesity and can influence their quality of life, 
lead to chronic pain, and contribute to a sedentary lifestyle which further increases obesity. 
Experimental Pain and Obesity 
Since the 1980s, researchers have been examining specific aspects of pain in individuals with 
obesity. This research can be difficult to evaluate since researchers have examined pain 
thresholds, pain sensitivity, and pain tolerance. Pain thresholds are defined as the minimum 
amount of stimuli required to produce a report of pain in an individual. Pain sensitivity is related 
to a subject's pain threshold level; an elevated pain threshold demonstrates that pain sensitivity 
has decreased. Pain tolerance is the maximum stimulus that a subject can endure. It can be 
difficult to summarize results from the variety of studies due to methods. Furthermore, there are 
conflicting results in experimental pain as to whether obesity in animals or adults contributes to 
higher or lower pain thresholds and tolerance (Table 1). 
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It is crucial to understand the difference between pain and nociception when comparing human 
and animal research. In humans, pain includes both the sensory and emotional aspects to a 
noxious stimulus. However, in animal research, pain must be classified as "nociception" 
because it does not include the emotional aspect and is inferred from the animal's behavioral 
response to a noxious stimulus. 
Animal research supports increased and decreased nociception assoyiated with obesity. Obese 
rats demonstrated attenuated nociception (a higher thermal threshold) by increased tail flick 
latency to a thermal stimulus compared to normal weight controls (Ramzan et al. 1993). In 
rabbits, obesity decreased the amount of time spent in pain behavioral responses in response to 
a 151 phase formalin test to the hind limb paw; this demonstrated an increased thermal threshold 
(Sinha et al. 2009). In contrast, Zucker rats (a genetic model for research on obesity and 
hypertension) exhibited shorter latencies to nociceptive mechanical stimuli in tail-flick and tail-
pinch methods than normal weighted ones (Roane and Porter 1986). There is minimal animal 
research in this area and it shows differences in nociception in response to experimental pain . 
In the animal model, nociception seems to be dependent on the stimulus, thermal versus 
mechanical. 
Human research also shows conflicting results with experimental pain associated with obesity. 
Research has shown that obesity is linked with higher pain thresholds (Khimich 1997; Maffiuletti 
et al. 2011; Raymond et al. 1995; Zahorska-Markiewicz et al. 1983; Zahorska-Markiewicz et al. 
1988). Pain thresholds to an electrical stimulus on the forearm and arm were observed to be 
higher in obese subjects over normal lean subjects; obese individuals appear to be less 
. . 
susceptible to pain with the correlation existing between overweight and the pain threshold 
(Zahorska-Markiewicz et al. 1983). Additional work by Zahorska-Markiewicz in 1988 
demonstrated that sensory and pain thresholds to an electrical stimulus on the forearm were 
higher in obese versus lean controls (Zahorska-Markiewicz et al. 1988). Pain detection 
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thresholds in response to a mechanical stimulus on the fingers were elevated in obese subjects 
when compared to controls with no significant differences in pain tolerance levels between the 
groups (Raymond et al. 1995). Higher pain thresholds to a mechanical stimulus on the forearm 
were also evident in subjects with excessive body weight in comparison to normal body weight 
controls indicating that they felt less pain (Khimich 1997). 
Not all human research with experimental pain shows increased pain thresholds and tolerance. 
In contrast, a lower sural nerve nociceptive-flexion reflex was demonstrated in obese women 
showing a significant reverse correlation between degree of overweight and the threshold of the 
nociceptive reflex (Pradalier et al. 1981). In obese subjects, pain sensitivity was increased as 
demonstrated by obese individuals displaying decreased mechanical pain thresholds assessed 
by a constant force applied to the finger (McKendall and Haier 1983). 
Significant differences in pain responses in obese animals and humans have been 
demonstrated in the previous research studies. There is noteworthy variability with the type of 
stimulus (mechanical , electrical, thermal) and the body location to which it was applied. Also, it 
is important to remember that experimental pain is not the same as clinical pain. The clinical 
reports of pain in obesity are very strong, but experimental pain is more variable. This suggests 
that in response to a noxious stimulus, obesity mayor may not attenuate pain thresholds and 
tolerance. 
The Chronic Inflammatory State of Obesity 
In order to understand the linking of pain and obesity through the mechanism of inflammatory 
markers, it is essential to know the substantial role that inflammatory marker:s play in obesity. 
Obesity is not just an imbalance of energy intake and expenditure. Adipose tissue is no longer 
considered a passive energy store but rather a major endocrine organ (Berggren et al. 2005; 
Ferris and Crowther 2011). Increased adiposity is linked to increased macrophage accumulation 
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and ultimately an increase in pro-inflammatory marker production which acts on a variety of 
physiological processes throughout the body (Weisberg et al. 2003). Specifically, inflammatory 
markers are secreted by adipose tissue and can create a persistent low-grade inflammatory 
state in obese individuals. These biologically active molecules are called cytokines or 
adipokines when they orig inate in adipose tissue. Cytokines are proteins and peptides that are 
secreted by cells which then act as cell messengers, including pro-inflammatory mediators. 
Cytokines can influence insulin sensitivity, glucose metabolism, inflammation and 
atherosclerosis (Cancello et al. 2006). Therefore, adipose tissue plays an important role in the 
complex cross-talk between organs regulating the body's homeostasis (Fischer-Posovszky et al. 
2007). 
The most commonly studied inflammatory markers associated with obesity are tumor necrosis 
factor a (TN Fa) and interleukin-6 (IL-6). In obesity, these inflammatory markers are linked with 
physiological mechanisms that lead to compromised health. TNFa, for example, can stimulate 
the production of atherosclerotic lesions leading to endothelial dysfunction and hypertension 
(Arslan et al. 2010; Lyon et al. 2003); furthermore TNFa impairs insulin signaling which 
negatively affects glucose transport (Keller et al. 2004; Umpaichitra 2006). IL-6 has been shown 
to negatively impact insulin sensitivity and endothelium functioning (Arslan et al. 2010) . 11-6 has 
been shown to inhibit TNFa production and increase the number of voltage-dependent sodium 
channels (Aderka et al. 1989; Satoh et al. 1988). The resultant inflammatory state, as 
demonstrated by elevated levels of TNFa and IL-6 in obese individuals , contributes to impaired 
metabolic and cardiovascular health associated with obesity (Wisse 2004). 
The Effects of Cytokines on the Nervous System 
In tissue injury, the initial role of cytokines is to sustain or reestablish homeostasis; however, 
sustained or excessive cytokine production can lead to damage (Rothwell and Hopkins 1995). 
Literature has shown that cytokines can negatively influence the function of neuronal cells 
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(Benveniste 1992). Also, the nervous system can both respond to cytokines and produce them 
(Hopkins and Rothwell 1995). Obese individuals with a chronic inflammatory state due to 
altered cytokine production may have different pain perception. For example, in obese 
individuals, elevated levels of TNFa and IL-6 are involved in the modulation of nociceptive 
pathways in both the peripheral and central nervous systems (Sommer 2001 ; aka et al. 1993; 
Ferreira et al. 1993; Bianchi et al. 1992). It is important to distinguish the potential mechanisms 
on these peripheral and central nervous system components to alter pain in obesity (Table 2) . 
Cytokines and the Peripheral Nervous System 
Cytokines, associated with obesity, offer the potential to affect the peripheral nervous system, 
specifically the afferent nociceptor. Changes in the environment from cytokine levels can 
influence sensory neurons to develop alterations which lead to modification of the transduction, 
conduction, and transmission functionality of these neurons (Cunha et al. 1992; Woolf and 
Costigan 1999). Sensitization of the pain receptor causes hyperalgesia and can be related to 
the inflammatory environment from dose-dependent levels of TNFa and IL-6 (Cunha et al. 
1992). 
With tissue injury, silent nociceptors are inactive under normal conditions but are activated by 
inflammation and can then respond to noxious or non-noxious (innocuous) mechanical stimuli 
(Kandel et al. 2000) . Silent nociceptors were initially discovered in response to injection of 
Kaolin , a clay substance used to mimic clinical pain (Schaible and Schmidt 1985; Schaible and 
Schmidt 1988). No research to date has assessed the role of cytokines in activating silent 
nociceptors, but it is hypothesized that cytokines may be part of the inflammatory impact in 
activating these silent nociceptors and creating pain associated with obesity. 
Another response to inflammation is peripheral sensitization , an increased responsiveness of 
peripheral afferent nociceptors after tissue injury. It affects the ability of the peripheral nervous 
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system to send information to the central nervous system. Peripheral sensitization is 
characterized by an increased firing rate of the nociceptor, decreased threshold for firing of the 
nociceptor, and increased release of excitatory neurochemicals such as substance P, aspartate, 
glutamate, and calcitonin gene related peptide (Sluka and International Association for the 
Study of Pain 2009). With peripheral sensitization, a larger pain signal is delivered to the spinal 
cord resulting in hyperalgesia. 
Aspects of peripheral sensitization are highlighted in the research work related to TNFa. An 
animal study showed that intraplantar (peripheral) injections of TNFa reduced mechanical 
nociceptive thresholds and induced mechanical allodynia (a noxious response to an innocuous 
stimulus) and thermal hyperalgesia in rats (Cunha et al. 1992). Through injection of TNFa on 
individual C nociceptors of the sural nerve of rats, it was demonstrated that TNFa sensitized C 
nociceptors (Junger and Sorkin 2000). TNFa injections into corresponding receptive fields also 
created transient bursting or more sustained and persistent C nociceptor activity (Junger and 
Sorkin 2000). The main components of peripheral sensitization may be occurring in response to 
peripheral exposure of TNFa. 
Another obesity cytokine, IL-6 is associated with increased pain and hyperalgesia (Sommer 
2001). IL-6 is suggested to significantly change the survival, histological behavior, and the 
functionality of cells related to nociception or pathologic pain (De Jongh et al. 2003). For 
example, IL-6 signaling starts an intracellular cascade system that shares intracellular signal 
proteins resulting in stronger nociception (De Jongh et al. 2003). Intraplantar injections of IL-6 
have produced hyperalgesia or allodynia in rats (De Jongh et al. 2003). Similarly, 
intramuscular IL-6 injections into mice resulted in long lasting mechanical hyperalgesia 
(Manjavachi et al. 2010). IL-6 has been shown to be a major element of the nociceptor 
environment that contributes to nociceptor sensitization and heat hyperalgesia (Obreja et al. 
Stalzman 9 
2002) . Obese individuals, who display elevations in IL-6, have evidence for a cytokine 
mechanism related to increased peripheral sensitization. 
In contrast, animal research also lends support for TNFa to alter pain via damage to the 
peripheral nerve itself. TNFa is known to directly cause demyelination and axonal degeneration 
in rats (Stoll et al. 1993). A delta nociceptors are myelinated and transmit the "first pain", while 
C nociceptors are unmyelinated and transmit the "second pain" (Kandel et al. 2000). However, 
if afferent fibers are demyelinated or potentially have axonal degeneration from increased 
exposure to TNFa, the first pain would be slower in transmission or unable to be transmitted to 
the spinal cord. This would result in decreased pain as a result from elevated TNFa exposure 
from obesity. While this is not demonstrated in the clinical pain associated with obesity, this 
may explain some of the experimental pain research results . 
Another peripheral aspect that cytokines may affect is prostaglandins which are one of the most 
important mediators of inflammatory tissue injury hyperalgesia. Prostaglandin synthesis, which 
is stimulated by a number of cytokines including TNFa and IL-6, is a major feature of both acute 
and chronic inflammatory states (Rothwell and Hopkins 1995). This increase in prostaglandins 
sensitizes sensory neurons, decrease their activation threshold, and enhance their responses to 
other stimuli (Dray 1995). TNFa promotes eicosanoid synthesis through stimulation of 
increased transcription of synthetic enzymes (Rothwell and Hopkins 1995). IL-6 participates in 
increased pain response (hyperalgesia) in response to TNFa through prostaglandins (Rothwell 
1991 ; Dinarello et al. 1991). Pro-inflammatory cytokines, such as TNFa and IL-6, increase 
prostaglandin synthesis. Therefore, there is a synergistic effect of hyperalgesia in obesity 
through several peripheral mechanisms. 
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Cytokines and the Central Nervous System 
Increasing evidence suggests that pro-inflammatory cytokines enhance pain via central 
mechanisms in both the spinal cord and brain. ChrQnic pain conditions induce pro-inflammatory 
cytokines in the spinal cord; intrathecal injections of these cytokines enhance pain; and spinal 
blockade of cytokines attenuates chronic pain (Kawasaki et al. 2008). In addition, cytokines 
may influence the central nervous system aspect of pain both directly and indirectly (Szelenyi 
2001). Unfortunately, less is known how these inflammatory cytokines specifically alter synaptic 
transmission and neuronal activity in the central nervous system. 
Central sensitization is an increased excitability of the nociceptive neurons in the central 
nervous system to their normal afferent input. The five main characteristics of central 
sensitization include: 1) increased receptive field size, 2) increased response to a noxious 
stimulus (hyperalgesia), 3) increased response to a non-noxious stimulus (allodynia), 4) 
increased spontaneous firing, and 5) decreased activation threshold (Sluka and International 
Association for the Study of Pain 2009). Pro-inflammatory cytokines, such as TNFa and IL-6, 
enhance pain via central mechanisms to accelerate central sensitization in rats (Kawasaki et al. 
2008). Specific to animals, intracerebroventricular or intrathecal injections of IL-6 have 
produced hyperalgesia or allodynia in rats (De Jongh et al. 2003). Due to elevated inflammatory 
markers secreted from adipose tissue, central sensitization may explain the increased pain 
associated with increased 8MI. 
A pivotal study investigating the cytokine mechanisms of central sensitization was completed by 
Kawasaki et al. in 2008. Kawasaki stated that "central sensitization is caused by increased 
excitatory synaptic transmission and decreased inhibitory synaptic transmission". Past research 
had shown that most neurons in lamina II (part of the spinothalamic tract) of transverse spinal 
cord slices are excitatory and pro-nociceptive (8aba et al. 2003; Kohno et al. 2005; Moore et al. 
2002; Yang et al. 1998). Through patch-clamp recordings in lamina II neurons of isolated spinal 
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cord slices of Sprague Dawley rats, the effects of TNFa and Il-6 on excitatory and inhibitory 
synaptic transmission were compared (Kawasaki et al. 2008). TNFa heightened the frequency 
of spontaneous excitatory postsynaptic current (EPSCs) to induce glutamate (an excitatory 
neurotransmitter) release from central terminals of primary afferents (Kawasaki et al. 2008; 
Saba et al. 2003) . In contrast, Il-6 decreased the frequency and amplitude of inhibitory 
postsynaptic currents (IPSCs) and suppressed inhibitory neurotransmission through 
suppression of GASA and glycine (inhibitory neurotransmitters) induced currents (Kawasaki et 
al. 2008) . In the superficial dorsal horn neurons of the spinal cord, the synaptic mechanisms of 
TNFa and Il-6 are individual but also corresponding through their actions of increasing 
excitatory synaptic transmission (TNFa) or decreasing inhibitory synaptic transmission (ll-6) to 
create central sensitization (Kawasaki et al. 2008) . Therefore, pro-inflammatory cytokines 
evident in the inflammatory state of obesity can induce central sensitization . 
In other experiments, injection of TNFa and Il-6 into spinal cord cerebral spinal fluid has 
created marked heat hyperalgesia (Kawasaki et al. 2008) . The overall effect of TNFa and Il-6 
are both pro-nociceptive, but specifically intrathecal Il-6 (a simulation of the effects of obesity) 
has produced allodynia in otherwise normal rats (Deleo and Yezierski 2001). These central 
injections simulate the increased pro-inflammatory cytokines evident in obesity to help explain 
heat hyperalgesia and allodynia. 
A final central nervous system component that is potentially affected by the chronic 
inflammatory state associated with obesity is the hypothalamus and hippocampus. Pain by 
definition is a both a sensory and emotional response; the central nervous system allows 
nociception to be transmitted to critical processing areas in the brain for these sensory 
discriminative (somatosensory cortex I and II) and motivational affective components (anterior 
cingulate and anterior insular cortex). These motivational-affective processing areas are 
intimately connected to the limbic system which contains the hypothalamus, known to regulate 
Stalzman 12 
the pain response, and the hippocampus, which plays a strong role in our emotional life and 
converts short-term memory to long-term memory (The Limbic System [Online]) . Brain research 
shows that the highest density of cytokine receptors are located in the hypothalamus and 
hippocampus, areas noted to be critical in pai'n processing (Hopkins and Rothwell 1995). If 
peripheral cytokines from adipose tissue are able to reach these central areas, they could be 
influencing pain regulation and pain memory formation. Additional research in this area is 
required to make more concrete statements about the potential role of peripheral cytokines from 
adipose tissue crossing the blood brain barrier and affecting central receptors in the 
hypothalamus and hippocampus. 
Cytokines and the Opioid System-A Peripheral & Central Effect 
Opioid receptors are located throughout both the peripheral and central nervous system. After 
tissue injury, opioid receptors are upregulated to reduce pain in inflamed tissues (Kandel et a!. 
2000). The opioid system is also affected by cytokines. IL-6 knockout mice demonstrate fewer 
opioid receptors in the midbrain, larger hypothalamic levels of l3-endorphin, and decreased 
analgesic response to morphine; therefore, IL-6 may be playing a role in the responses to 
nociceptive stimuli and modulating the opioid pathway (Bianchi et a!. 1992). It has also been 
demonstrated that morphine is less potent in obese versus lean rats suggesting a defect in the 
endogenous opioid systems of obese Zucker rats (Roane and Porter 1986). Increased opioid 
receptors have been found in obese animal models of obesity (Cozzolino et a!. 1996; Smith et 
a!. 2002); a possible link between obesity and the opioid receptors density could be cytokines 
associated with obesity. In addition, increases in endogenous opioid levels have been reported 
in obese humans (Cozzolino et a!. 1996; Givens et al. 1980; Karayiannakis et a!. 1998). 
Another reason for the variability of results in the experimental pain studies may be the 
influence of cytokines on the opioid receptor representation and opioid levels in obese 
individuals leading to decreases in pain. 
Stalzman 13 
The changes to the opioid system from cytokines may be indirect as ghrelin may be the 
mediator. Ghrelin is a hormone related to obesity that affects hunger; obese individuals have 
decreased levels while lean individuals have increased levels. Ghrelin receptors have been 
shown to be expressed in various brain areas that influence the transmission of noxious 
messages such as the brainstem and hypothalamus (Kojima and Kangawa 2005; Zigman et al. 
2006). Both intracerebroventricular, intraperitoneal, and intraplantar ghrelin have been shown 
to effectively counteract the development of hyperalgesia induced by intra plantar carrageenan 
(a seaweed derivative to induce inflammation) in rats (Sibilia et al. 2006). Therefore, ghrelin 
acts as an inhibitor on inflammatory pain through an interaction with the central opioid system 
(Sibilia et al. 2006). In obese individuals, ghrelin is decreased resulting in less inhibition. 
Whether administered centrally or peripherally, ghrelin exerts an inhibitory role on the 
development of inflammation and hyperalgesia (Sibilia et al. 2006). This inhibitory role evolves 
from ghrelin inhibiting the expression of pro-inflammatory cytokines such as TNFa and IL-6 
(Dixit et al. 2004). These cytokines contribute to both central and peripheral inflammatory pain 
hypersensitivity (Samad et al. 2001). With the decrease in ghrelin in obese individuals, IL-6 and 
TNFa remain elevated and may be even higher in obese individuals due to additional production 
by adipose tissue; this would increase pain. 
Conclusion 
The obesity epidemic has created a significant public health concern with the majority of obese 
individuals reporting clinical pain. Obesity and clinical pain have an established connection in 
literature across the lifespan, but consensus over the true definition of altered experimental pain 
in obesity is not set. Obese individuals demonstrate elevated levels of cytoKines, such as TNFa 
and IL-6, which can create a chronic inflammatory state leading to impaired health (Figure 1). 
These inflammatory markers associated with obesity are also related to pain signaling and 
transmission in both the peripheral and central nervous systems. Therefore, cytokines may be 
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altering the neurophysiological properties of peripheral nociceptors and central neurons via 
quantitative changes in inflammation involved in nociception . Peripheral and central 
sensitization may be enhanced by cytokines. In addition , prostaglandins and the opioid systems 
may be influences by cytokines . Not ali pain research involving cytokines supports the 
increased report of clinical pain in obesity , but this conflict may expound the variability in 
research results involving experimental pain. 
Future Research 
These conflicts in research in both animal models and humans provide numerous avenues for 
additional research in the study of obesity-associated pain. Future research involving 
assessment of obesity variables (8MI and measures of body composition) , peripheral and 
central cytok ine levels, and pain thresholds/tolerance levels are needed to see the direct and 
indirect mechanisms of cytokines on pain in the peripheral and central nervous system. A large 
amount of the research has been completed in animal models where aspects of emotion and 
social influence are not as strong as in humans. Additional research is necessary in humans to 
establish the association of pain reports in individuals with obesity and the inflammatory state 
created by cytokines from obesity. Obesity interventions, such as physical activity and exercise, 
promote changes in body composition through decreases in fat mass. This change in fat mass 
may decrease the inflammatory state brought on by adipose tissue. Ultimately, exercise may 
decrease pain because less pro-inflammatory cytokines are enhancing peripheral and central 
sensitization. In addition , exercise may also promote an anti -inflammatory state and decrease 
pain through exercise induced hypoalgesia. Adults and pediatric studies are need in this area to 
determine how exercise influences changes in cytokine expression on pain in obesity during 
acute and long term exercise training. 
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Table 1 E tal Pain Alt d in Obesitv? 
Animal Human Pain or Pain or No 
Author Year Study Study Noc t Noc 
'" 
Change Results 
.../ .../ Higher pain thresholds to mechanical stimulus on the forearm in subjects with excessive body 
Khimich 1997 weight compared to normal weight controls. 
.../ ,./' Decreased mechanical pain thresholds in obese McKendall & Haier 1983 individuals. 
,./" ,./' Lower sural nerve nociceptive-flexion reflex in 
Pradalier et al. 1981 obese women. 
,./" 
.../ Increased thermal pain threshold as observed by 
Ramzan et al. 1993 increased tail flick latency in obese animals. 
J" 
Elevated pain detection thresholds to mechanical 
~ ../ stimulus on fingers in obese compared to 
controls. No significant differences in pain 
Raymond et al. 1995 tolerance thresholds between the groups. 
.../' 
'" 
Decreased latency to nociceptive mechanical 
stimuli by Zucker (obese) rats than normal weight 
Roane & Porter 1986 rats. 
,./' ,./' Increased thermal threshold by decreased time in pain behaviors in response to formalin test with 
Sinha et al. 2009 obese rabbits . 
,./' .../' Elevated pain thresholds in obese subjects over normal lean controls in response to electrical 
Zahorska-Markiewicz 1983 stimulus on forearm and arm. 
.../' .../ Sensory and pain thresholds were higher in obese versus lean controls from electrical 
Zahorska-Markiewicz 1988 stimulus on forearm. 
Table 2: Are TNFa or IL-6 a Possible Mechanism that Alters Nociception/Pain in the PNS or CNS? 
I 
Animal Human CNS PNS 
Author Year Study Study TNFa IL-6 Effect Effect Notes 
Baba H et al. 2003 ~ ~ ~ Central Sensitization 
Bianchi M et al. 1992 ~ .../ .../ Opioid system 
Cunha, FQ et al. 1992 .../ .../ ~ Peripheral Sensitization 
De Jongh RF et al. 2003 .../ ~ .../ .../ Central & Peripheral Sensitization 
Deleo JA & Yezierski RP 2001 .../ .../ .../ .../ Central Sensitization 
Dinarello CA et al. 1991 ../ .../ ~ Prostoglandins role 
Dixit VD et al. 2004 ~ ~ ~ .../ Ghrelin as mediator 
Ferreira SH et al 1993 .../ ../ .../ .../ .../ Central & Peripheral Sensitization 
Junger H & Sorkin lS 2000 .../ .../ ../ Peripheral Sensitization 
Kawasaki Y et al. 2008 .../ .../ .../ ~ Central Sensitization 
Manjavachi MN et al. 2010 .../ .../ .../ Peripheral Sensitization 
Obreja 0 et al. 2002 ~ .../ .../ Peripheral Sensitization 
Samad TA et al. 2001 ~ ~ J' .../ ~ Ghrelin as mediator 
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Figure 1: The Influence of 
Increased opioid Cytokines in Obesity-
Peripheral 
Sensitization 
receptors Central Associated Pain. Adipose 
Sensitization tissue produces the 
PNS eNS 
cytokines TNFa and IL-6. 
These cytokines affect the 
peripheral and central 
nervous systems to increase 
pain associated with obesity 
through peripheral and 
central sensitization. TNFa 
and IL-6 also increased 
prostaglandin synthesis 
which increases pain. 
Ghrelin may be a mediator 
between the link of 
cytokines and the opioid 
system to increase pain in 
obese individuals. Physical 
activity is a critical 
intervention to decrease 
adiposity, inflammatory 
markers, and pain to 
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